Dubai Hosts the 6th Edition of the Middle East, Africa and Russia Hematology Summit “MASH”
The Hematology Medical Conference, sponsored by AbbVie, the global research and development…
Dubai Hosts 5th International Neuroscience Summit for Middle East, Africa, and Russia Region
The International Neurology Conference for the Middle East, Africa and Russia kicked…
AbbVie and ADARx Announce $335 Million Collaboration to Develop Cutting-Edge RNA Therapeutics
AbbVie and ADARx Pharmaceuticals, a late clinical-stage biotechnology company developing next-generation RNA…
European Commission approves AbbVie’s RINVOQ® for treatment of Giant Cell Arteritis
1.RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved…
AbbVie acquires Nimble Therapeutics to advance autoimmune and psoriasis treatments
December 2024- AbbVie and Nimble Therapeutics announced a definitive agreement under which…
AbbVie Awards Scholarships to 45 Students with Chronic Diseases
NORTH CHICAGO, Ill- AbbVie recently announced the 2024-2025 recipients of the AbbVie…
EU Approves TEPKINLY® for Relapsed/Refractory Follicular Lymphoma
NORTH CHICAGO, Ill.- AbbVie recently announced that the European Commission (EC) has…
AbbVie Completes Acquisition of Cerevel Therapeutics
North Chicago- August 2024- AbbVie announced that it has completed its acquisition…
AbbVie Launches Contest to Empower People Living with Migraine in their Careers
June 20204- AbbVie launched the AbbVie Migraine Career Catalyst Award, a first-of-its-kind…
AbbVie Completes Acquisition of Landos Biopharma
North Chicago- May 2024- AbbVie announced that it has completed its acquisition…